Home LiteratureArticle Details
PMID: 18227014 Published · ppublish chi

[Inhibition of COL1A1 and COL3A1 expression by RNA interference in human skin fibroblasts].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University ·Vol. 28 ·No. 1 ·2009-04-13

Wang Qiong, Peng Zhen-Hui, Wang Wan-Juan

Abstract

To suppress COL1A1 and COL3A1 gene expressions in human skin fibroblasts (HSFs) by means of RNA interference (RNAi).,Three small interfering RNA (siRNA) expression cassette (SEC) sequences were designed for each of the COL1A1 and COL3A1 gene sequences available in GenBank. The synthesized SECs capable of effective gene suppression were transfected into cultured HSFs, either after cloning into the expression vector or mediated by Lipofectamine 2000, and the suppression of the target genes at both mRNA and protein levels was determined by quantitative fluorescence RT-PCR and Western blotting, respectively.,Transfection of the SECs into HSFs resulted in specific depression of COL1A1 and COL3A1 expressions (down to 5.00% and 6.48%, respectively). The expression vector-mediated RNAi established a HSF cell line with persistent gene knockdown for over 30 days (to 25.21% and 22.12%, respectively).,COL1A1 and COL3A1 gene expressions can be specifically and efficiently inhibited in HSFs by either liposome- or vector-mediated SEC transfection.

Article Info
Journal
Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Abbr.
Nan Fang Yi Ke Da Xue Xue Bao
ISSN
1673-4254
Published
2009-04-13
Indexed
2008-01-29
Updated
2008-01-29
Language
chi
Country/Region
China
NLM ID
101266132
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]